Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
Revenue for Adverum Biotechnologies (ADVM)
Revenue in 2023 (TTM): $3.6 M
According to Adverum Biotechnologies
's latest financial reports the company's current revenue (TTM
) is $3.6 M.
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of $7.5 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Adverum Biotechnologies from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.6 M | |
| 2022 | N/A | -100% |
| 2021 | $7.5 M | |
| 2020 | N/A | -100% |
| 2019 | $0.25 M | -84.49% |
| 2018 | $1.61 M | -12.82% |
| 2017 | $1.84 M | 27.08% |
| 2016 | $1.45 M | -37.26% |
| 2015 | $2.31 M | 305.42% |
| 2014 | $0.57 M | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |